Kerstin F. Gerer

Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy

Julio Vera, Xin Lai, Florian S. Dreyer, 2021, Theranostics.

Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy

Florian S. Dreyer, Kerstin F. Gerer, A. Ekici, 2020, bioRxiv.

Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.

Kerstin F. Gerer, J. Dörrie, N. Schaft, 2017, Methods in molecular biology.

Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells

Kerstin F. Gerer, D. Cavalieri, J. Vera, 2015, Journal of immunology research.

Triggering of NF‐κB in cytokine‐matured human DCs generates superior DCs for T‐cell priming in cancer immunotherapy

Kerstin F. Gerer, G. Schuler, R. Voll, 2014, European journal of immunology.

Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination

Kerstin F. Gerer, S. Hadrup, G. Schuler, 2017, Therapeutic advances in medical oncology.

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Kerstin F. Gerer, G. Schuler, S. Fujii, 2017, BMC Cancer.

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Kerstin F. Gerer, G. Schuler, S. Fujii, 2017, BMC Cancer.

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

Kerstin F. Gerer, L. Heinzerling, G. Schuler, 2018, International journal of molecular sciences.